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ABSTRACT
Synthesis of a Water Soluble Resveratrol Derivative as a Potential Anti-Cancer Drug
by
Augustine Foster Essel

Research on development of water soluble anti-cancer drugs is one of the great challenges of
modern medicinal chemistry. Resveratrol (Res) is one of the many phytoalexins producing
stilbenoids present in several medicinal plants, grape skin, peanuts, and red wine. It has been
found to exhibit anti-cancer, anti-inflammatory, and anti-oxidant properties. Water solubility and
bioavailability are some of the setbacks of this interesting compound. In view of this, effort has
been made to synthesize amino acid derivative of resveratrol to improve its bioavailability and
solubility in water. Methyl 4-{-[(1E)-2-(3, 5-dihydroxyphenyl)-ethenyl] - phenoxy} butyrate (7),
a novel ester intermediate, has been synthesized and could be subjected to further chemical
transformations to obtain amino acid derivatives.
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CHAPTER 1
INTRODUCTION
Research on development of water soluble anti-cancer drugs is one of the great
challenges of modern medicinal chemistry. In view of this, effort has been made to synthesize
water soluble resveratrol derivatives.
Biology of Cancer
Naturally, our body cells are programmed to divide, grow, and die. Damage to DNA can
cause cells to experience uncontrolled growth and, therefore, damage to the genes involved in
cell division. The four key types of genes which are responsible for the cell division process are:
oncogene, which tell cells when to divide, tumor suppressor genes tell cells when not to divide,
suicide genes control apoptosis and tell the cell to kill itself if something goes wrong, and DNArepair genes instruct a cell to repair damaged DNA [1] . Cancer occurs when a cell's gene
mutations make the cell unable to correct DNA damage and unable to commit suicide [1].
Carcinogens are a group of substances that cause damage to DNA, promoting or aiding
cancer. Tobacco, asbestos, arsenic, radiation such as gamma and x-rays, the sun, and compounds
in car exhaust fumes are all examples of carcinogens [1]. When our bodies are exposed to
carcinogens, free radicals are produced that in turn react with other molecules in the body. There
are five broad groups that are used to classify cancer [1].
1. Carcinomas are characterized by cells that cover internal and external parts of the body
such as lung, breast, and colon cancer.
2. Sarcomas are characterized by cells that are located in bone, cartilage, fat, connective
tissue, muscle, and other supportive tissues.
3. Lymphomas are cancers that begin in the lymph nodes and immune system tissues.
4. Leukemia is cancers that begin in the bone marrow and often accumulate in the
bloodstream.
5. Adenomas are cancers that arise in the thyroid, the pituitary gland, the adrenal gland, and
other glandular tissues.
Cancer Treatment
One of the following six categories can be used as a treatment method for cancer:
surgery, radiation, chemotherapy, immunotherapy, hormone therapy, and gene therapy.
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Surgery
This kind of cancer treatment is useful at the onset of the cancer cells when they have
not spread to other part of the body. In this case it is possible to completely cure a patient by
surgically removing the cancer from the body. This is often seen in the removal of the prostate or
a breast or testicle. After the disease has spread, however, it is nearly impossible to remove all of
the cancer cells. Surgery may also be instrumental in helping to control symptoms such as bowel
obstruction or spinal cord compression [1].
Radiotherapy
Radiation treatment also known as radiotherapy kills cancer cells by using or exposing
high-energy rays on the cancer cells. High energy rays causes damage to the molecules that make
up the cancer cells and lead them to commit suicide. Radiotherapy uses high-energy gamma-rays
that are emitted from metals such as radium or high-energy x-rays that are created in a special
machine. Early radiation treatments caused severe side-effects because the energy beams damage
normal, healthy tissue, but technologies have improved so that beams can be more accurately
targeted. Radiotherapy is used as a standalone treatment to shrink a tumor or destroy cancer cells
(including those associated with leukemia and lymphoma), and it is also used in combination
with other cancer treatments [1].
Immunotherapy
Immunotherapy aims to get the body's immune system to fight the tumor. Systemic
immunotherapy treats the whole body by administering an agent such as the protein interferon
alpha that can shrink tumors. Immunotherapy can also be considered non-specific if it improves
cancer-fighting abilities by stimulating the entire immune system, and it can be considered
targeted if the treatment specifically tells the immune system to destroy cancer cells. These
therapies are relatively young, but researchers have had success with treatments that introduce
antibodies to the body that inhibit the growth of breast cancer cells. Bone marrow transplantation
(hematopoietic stem cell transplantation) can also be considered immunotherapy because the
donor's immune cells will often attack the tumor or cancer cells that are present in the host [1].
Gene Therapy
The objective of gene therapy is to replace damaged genes with ones that work to
remove a root cause of cancer, damage to DNA. Interesting research are been done to replace the
damaged gene that signals cells to stop dividing (the p53 gene) with a copy of a working gene.
12

Other gene-based therapies focus on further damaging cancer cell DNA to the point where the
cell commits suicide [1].
Chemotherapy
Chemist plays an important role when it comes to chemotherapy and intense research is
being done to develop potent chemotherapeutic drugs. Chemotherapy uses chemicals that
interfere with the cell division process - damaging proteins or DNA - so that cancer cells will
commit suicide. These treatments target any rapidly dividing cells (not necessarily just cancer
cells), but normal cells usually can recover from any chemical-induced damage while cancer
cells cannot. Chemotherapy is generally used to treat cancer that has spread or metastasized
because the medicines travel throughout the entire body. It is a necessary treatment for some
forms of leukemia and lymphoma. Chemotherapy treatment occurs in cycles so the body has
time to heal between doses. However, there are still common side effects such as hair loss,
nausea, fatigue, and vomiting. Combination therapies often include multiple types of
chemotherapy or chemotherapy combined with other treatment options [1].
Natural Compounds with Health Benefits
Polyphenols
Polyphenols are naturally occurring compounds that have been found to affect cancer
cell growth and they have attracted great research attention. Initial evidence came from
epidemiologic studies suggesting that a diet that includes regular consumption of fruits and
vegetables (rich in polyphenols) significantly reduces the risk of many cancers [2]. The anticancer properties of polyphenols can be attributed to their ability to act as anti-oxidants, and also
to their ability to interact with basic cellular mechanisms. These cellular interactions include
interference with membrane and intracellular receptors, modulation of signaling cascades,
interaction with the basic enzymes involved in tumor promotion and metastasis, interaction with
oncogene, and oncoproteins [2]. Their great properties could be significantly exploited in the
field of oncology.
Classification and Nomenclature of Polyphenols
Polyphenols are classified by the presence of more than one phenol unit or building
block per molecule. Generally, they are divided into hydroxylable tannins, phenylpropanoid
such as lignin, and flavonoids as shown in Figure 1 [3].

13

The type of phenonic subcomponent could also be used as a basis for classifying
Polyphenols. More than one subcomponent can be present on a given Polyphenols. Examples are
shown Figure 2 [3].
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Figure 2. Nomenclature of polyphenols based on phenolic subcomponent

Selected Natural Compounds with Anti-Cancer Properties

Naphthoquinones

In recent years, some naphthoquinone derivatives such as Juglone 2 have been found to
exhibit anti-bacterial, anti-fungal, and anti-viral properties and they could be used as anti-cancer
agent because they can provoke cell apoptosis [4].
5-hydroxy-1,4-naphthalenedione (Juglone) is a naphthoquinone pigment that occurs as a
natural product in the roots, leaves, nut, bark, and wood of black walnut (Junglans, nigra) and
European Walnut ( Junlars ,regia) and butter nut (Junglans, cinerea) [5].
Juglone is an allelopathic compound, meaning it is synthesized by one plant and affect
the growth of another. In the case of Juglone it is toxic or growth-stunting to plants. Landscapers
have long known that gardening underneath or near black walnut tree can be difficult. Juglone
exerts it effect by inhibiting certain enzymes needed for metabolic functions. Nonetheless, a
number of plants are resistant to Juglone, example fagus, Acer, and others [6].
Crushed unripe walnut hulls have been used for generation in various types of folk
medicine. The hulls are made into poultices and robbed into the skin to treat bacterial or fungal
infections such as herpes or warts. External application of black walnut also kills ring worm, and
Chinese herbalist use this substance to kill tape worm. Juglone, due to its ability to create dark
15

orange-brown stains, has been used as coloring agent for foods and cosmetics such as hair dye. It
is known in food industry as C.I Natural Brown 7 or C.I 75500. Traditionally Juglone has been
used as natural dye for clothing and fabrics, particularly wool. It has also been used as Ink [5].
Between 1976 and 1999, 73 patent involving Juglone were obtained in the United State
(Us patent and Trademark office, 1999). These patents demonstrated a variety of potential uses
for juglone, for example to prepare antiviral naphthoquinone derivatives useful for AIDs
treatment (Kurtz et al, 1996, Boyd et al, 1999).
Flavonoids
Flavonoids are group of natural occuring polyphenols that have also atrracted great
research attention. They include several thausand compounds such as those shown in Figure 3
[6]. Flavonoids constitute a group of natural compounds that occur in fruits and vegetables, wine,
and tea[7]. Scientists in the fields of nutritional biochemistry and medicinal chemistry have
gained much interst in these compunds.The centre of attraction of these compounds could be
attributed to the following reasons; first, these polyphenols exert potent anti-oxidants actions in
numerous in vitro systems[7,12].. Second, the dietry intake of flavonoids and similar
polyphenols exceeds that of anti-oxidative vitamins and provitamins. In epidemiologic studies,
increase intake of flavonoids was associated with reduced risk of major cardiac events [9,10].
The health benefits of flavanoids are mainly attributed to their free radical scavenging properties
thus counterreacting conditions of oxidative stress that accompany disorders such as coronary
artery disease, and their vascular diseases, stroke, inflamatory diseases, and cancer [9].

Figure 3. Flavonoids continued on next page
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Figure 3. Flavonoids
Resorcinol
The chemistry of resorcinol is of great interest to bioorganic or natural product scientists
due to its structural significant. The OH groups on resorcinol form hydrogen bonds to target
molecules, holding them in a proper orientation for reaction. Research has indicated that most
food supplements containing resorcinol moiety have potential anti-inflammatory, anti-oxidant,
and anti- tumor properties. Some examples of natural occurring polyphenols with resorcinol
moiety are quercetin, kaempferol, genistein, and resveratrol as shown in Figure 4.
Quercetin
Quercetin is a food supplements and it exhibit anti-inflammatory activities by inhibiting
both manufacture of and release of Histamine and other allergic and inflammatory mediators. It
also exerts potential anti-oxidant and vitamin C- sparing action [10]. Recent studies have
supported that quercetin may help men with chronic prostatitis and both men and women with
interstitial cystitis, possibly because of its action as mast cell inhibitor [11, 12].
Kaempferol
Kaempferol is another interesting natural flavanoid that has been isolated from tea,
broccoli, grapefruits, apples, and other plant sources. Kaempferol consumption in tea and
broccoli has been associated with reduced risk of heart disease [13].
Genistein
Genistein and other flavones have been found to have anti-angiogenic effects (blocking
formation of new blood vessels) and may block the uncontrolled cell growth associated with
cancer, most likely by inhibiting the activity of substances in the body that regulate cell division
and cell survival (growth factors) [14]. Various studies have found moderate doses of Genistein
17

to have inhibitory effects on cancers of the prostate, cervical, brain, breast, and colon [14].
University Of Califonia, Los Angeles (UCLA) cancer researchers have found that study
participants who ate foods containing certain flavanoid seemed to be protected from developing
lung cancer. Dr. Zuo-Feng Zhang of the UCLA's Jonsson Cancer Center and a professor of
public health and epidemiology at the UCLA School of Public Health said the flavonoids that
appeared to be the most protective included catechins found in strawberries and green and black
teas; Kaempferol, found in brussel sprouts and apples; and quercetin, found in beans, onions ,
and apples [15].

Figure 4. Compounds containing resorcinol moiety
Chemistry of Resveratrol and Its Derivatives

Resveratrol (Res) is one of the many phytoalexin producing stilbenoid present in several
medicinal plants, grape skin, peanuts, and red wine [16]. In addition to its phytoalexin effect, it is
also believed that it protects the plant against oxidative stress and UV radiation [17].
Biosynthesis of resveratrol occurs by the action of key enzyme, stilbene synthase (StSy) that
18

converts one molecule of P-coumarol-CoA and three molecules of malonyl CoA into resveratrol
[18]. Malonyl CoA is derived by elongation of acetyl CoA units, while P-Coumaroyl-CoA from
phenylalanine which in plants can be synthesize from sugars via Shikimate pathway [19].
The properties of resveratrol cannot be well understood without considering the
chemistry of Stilbenes. Stilbenes are diarylethene and basically they are hydrocarbons consisting
of trans or cis-ethane double bond substituted with phenyl groups on both carbon atoms of the
double bond. They exist in two isomeric forms: The first isomer is trans-1, 2-diphenylethylene
also known as (E)-stilbene. The second isomer is cis-1, 2-diphenylethylene commonly referred to
as (Z)-stilbene. The Z isomer is sterically hindered and less stable because the steric interactions
forces the aromatic rings out of plane and prevent conjugation. Cis-stilbene has melting point of
5-6oC, while the trans-stilbene melts around 125oC [20].
Derivatives of Stilbene
Many stilbene derivatives, chemically referred to as stilbenoid are present naturally in
plants and are known to act as phytoalexins that help to improve the plant‟s defensive
mechanism against pathogens [21]. Resveratrol and its cousin pterostilbene are examples of
stilbenoid. Other examples that are suggested to have varied health benefits include piceatannol
and pinosylvin .The chemistry of each mention above is discussed briefly.
Pterostilbene
Pterostilbene is chemically related to resveratrol and it is thought to be the key
compound found predominantly in blueberries (as well as grapes) that exhibit anti-cancer (breast
cancer), hypercholesterolemia, anti-hypertriglycridemia properties as well as fight off and
reverse cognitive decline. It is believed that the compound also has anti-diabetic properties but so
far very little has been studied on this issue [22].
Unlike resveratrol, which is found in red wine, pterostilbene is not present in wine
because it is not stable in light and air. It is also believed that pterostilbene metabolizes slowly as
compared with resveratrol [22].
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Piceatannol
3, 4, 3‟, 5‟-tetrahydroxy-trans-stilbene, commonly known as piceatannol, is a phenol
stilbenoid. It is the metabolite of resveratrol found in red wine. LMP2A, a viral proteintyrosinekinase implicated in leukemia, Non-Hodgkin‟s Lymphoma, and other diseases associated
with Epstein-Barr virus (EBV) also called human herpesVirus4 (HHV-4), was found to be
blocked by piceatannol in vivo. These preliminary studies on piceatannol have attracted a lot of
research attention as a potential anti-cancer and anti-EBV drug [23].

Pinosylvin
Pinosylvin is a pre-infectious stilbenoid toxin (synthesized prior to infection) contrary to
phytoalexins which are synthesized during infection. It is a fungi-toxin protecting the wood from
fungal infection [24]. In 2005 S.K.Lee et al. reported that pinosylvin could exhibit more potent
growth inhibitory activities against Candida albicans and Sacchraromyces cerevisiae compared
to resveratrol [25]. Derivatives of pinosylvin have been reported to exhibit anti-cancer properties
[26].
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Early Discovery and History of Resveratrol
It is believed that resveratrol was first mentioned in Japanese article in 1939 by
M.Takaoka, who isolated it from the poisonous but medicinal Veratrum album [27]. The name is
presumed to have „coined‟ from resorcinol (the fact that it is resorcinol derivative) and Veratrum
species (the plant it was first isolated from) [27]. Until today it is believed that resveratrol has
also been isolated from roughly 70 different plant species, most important of which is the skin
and seeds of red grapes [28].
Recent Studies and Applications
Within the past decade, it has become increasingly clear that resveratrol posses
significant health benefits to humans and could be potent chemo-preventative agent for several
different health related problems including cancer, cardiovascular diseases, ischemia, and aging
[29, 30].
Anti-Aging/Life Extension
The fact that Res could be used as anti-aging agent attracted enormous attention
worldwide. Here are some of captured „Res making headlines‟


“The belief that aging is still an unsolved problem is longer true” - Hayflick, San
Francisco School of Medicine. 2007



“The most phenomenon discovery since antibiotics” - Sinclair Harvard University, 2003



“Aging as we know it may not be inevitable” - Newsweek Magazine Dec 4, 2006



“We may all soon be taking a pill that could give as extra decade or two of healthy old
age” - CBS News (60 minutes), May 25, 2009



“Living well past 100 could actually be possible” - Barbara Walters, CBS NEWS (Live
to 150) May 13, 2009

The notion that aging requires treatment is because aging is a negative term that connotes
deterioration, approaching pathology, and death [31].
In 2003 the groups of Howitz and Sinclair reported in the journal Nature that Res
significantly extends the life of the yeast Sacchraromyces cerevisiae [32]. Sinclair later
conducted some studies that showed Res could also prolonged the lifespan of the worm
Caenorhabdities elegans and the fruit fly Drosophila melanogaster [33].
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In 2007 Sinclair‟s result was reproduced by a different group of scientists using
C.elegans [34]. Unfortunately, a third group of researches could not achieve consistent increases
in lifespan of D.melanogaster or C.elegans [35]. The first positive result of Res supplementation
in a vertebrate was obtained by Italian scientists in 2006. A Short-lived fish Nothobrachius
furzeri, with a median life span of nine weeks was used .They found that a maximal dose of Res
increased the median lifespan by 56%. The studies showed that the fish supplemented with Res
showed significant higher general swimming activity and better learning to avoid an unpleasant
stimulus [36].
Resveratrol as Anti-Cancer Compound
Trans-Res have been reported to have multiple health related benefits to humans. Such
health benefits include anti-inflammatory and cancer chemo-preventative potentials [37]. For the
past few years scientists have devoted much time and resources to research the biological activity
of Res, especially the anti-oxidant activity because free radical-induced peroxidation of
membrane lipids and oxidative damage of DNA have been considered to be associated with a
wide variety of chronic health problems such as cancer, atherosclerosis, and aging and gene
transcription can be regulated by oxidants, anti-oxidants, and other determinants of the
intracellular redox state[38,39,40].
It has also been reported that Res is a good anti-oxidant against the peroxidation of lowdensity lipoprotein (LDL), liposome [41]. Research has also proven the anti-oxidant activity of
Res is related to its hydroxyl (OH) groups which can scavenge free radicals produced in vivo
[41]. It has also been revealed that Res has potential inhibitory effects on cyclooxygenase [37],
rat liver mitochondrial ATPase [42], Human F1 ATPase [43, 44], and tyrosinase [45]. It is
believed that Res is currently in clinical phase II trials as an anti-cancer drug for treatment of
human colon cancer [46]. In addition to the above studies, Res has been shown to inhibit the
activation of the oncogene transcription factor NF-kB by various inflammatory agents [46]. In
1997, Jang reported that topical Res applications prevented skin cancer development in mice
treated with a carcinogen [37]. It has been reported that in vitro Res interacts with multiple
molecular targets and damaged cells of breast, skin, gastric, colon, esophageal, prostate , and
pancreatic cancer and leukemia [48].
The study of pharmacokinetics of Res in humans revealed that even high doses of Res
might be insufficient to achieve Res concentration required for the systemic prevention of cancer
22

[49]. This result was consistent with the results from the animal cancer models, which indicated
that the in vivo effectiveness of Res is limited by its poor systemic bioavailability [50, 51].

Other Suggested Applications
Researchers at the Weil Medical College of Cornell University came up with a report in
2006 which indicated that dietary supplementation with Res significantly reduced plaque
formation in animal brains, a component of Alzheimer and other Neurodegenerative diseases
[52]. The results explained that in mice oral Res produced large reductions in brain plaque in the
hypothalamus (-90%), striatum (-89%), and medial cortex (-48%) sections of the brain [53].
Researchers have come up with the theory that one mechanism for plaque eradication is the
ability of resveratrol to chelate copper [54].
Anti-Inflammatory Effect
Resveratrol (Res) is also believed to posses anti-inflammatory effects and this has been
demonstrated in several studies using animal models. In a rat model of carrageenan-induced paw
edema, Res inhibited both acute and chronic phases of the inflammatory process [55].
Cardio-Protective Effect
Epidemiological studies have shown that cardiovascular and cerebrovascular ischemic
events are decreased by moderate wine consumption [57]. This study is consistent with the fact
that red wine is the most important dietary source of Res [57], and it has been suggested that Res
is at least partly responsible for the so-called „French paradox‟, which refers to the reduced
incidence of cardiovascular diseases in region of French where saturated fats are consumed in
even larger quantity than in US where red wine are consumed in far larger quantity [58]. It
achieves the effects by the following functions: (1) Inhibition of vascular cell adhesion
molecules expression, (2) Inhibition of vascular smooth muscles cell proliferation, (3)
Stimulation of endolethelial nitric oxide synthase (eNOS) activity, (4) Inhibition of platelet
aggregation, (5) Inhibition of LDL peroxidation [54, 55].
Anti-Diabetic Effect
Studies have shown that resveratrol possesses hypoglycemic and hypolipidemic effects in
both streptozotocin (STZ)-induced diabetes rats and STZ-nicotinamide-diabetes rats. Res
ameliorate common diabetes symptoms such as polyphagia, polydipsia, and body weight loss. In
human clinical trials, resveratrol has lowered blood sugar levels in both Phases 1b and Phase IIa,
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conducted by Sirtris Pharmaceutical, Inc [58].
Anti-Viral Effect
Studies show that resveratrol inhibits herpes simplex virus (HSV) types 1 and 2
replication by inhibition of an early step in the virus replication cycle. In vivo studies in mice
show Res inhibits or reduces HSV replication in the virgina and limits extra-virginal diseas.The
skin of resveratrol-treated animals showed no apparent dermal toxicity such as erythema, scaling
crusting, lichenification, or excoriation. Studies also show that resveratrol inhibits varicellazoster virus, certain influenza virus, respiratory viruses, and human cytomegalovirus [59].
Pharmacokinetics of Resveratrol
Resveratrol seems to provide an important lead as a cancer chemo-preventative or
chemo-therapeutic agent but pharmacokinetics studies have revealed a number of setbacks in
relation to its absorption, metabolism, and bioavailability. Experimental results have revealed
that one way of administering resveratrol in humans appears to be buccal delivery (without
swallowing) by direct absorption through the inside of the mouth. This study showed that when
one mg of Res in 50 mL solution was retained in the mouth for one min before swallowing,
37ng/ml of free Res were measured in plasma two minutes later. It was further explained that all
resveratrol that enters the blood circulation would be converted to molecules such as
glucuronated and sulfate as it passes through the liver [60]. It also believed that about 70% of the
resveratrol dose given orally as a pill was absorbed; but oral bioavailability of resveratrol was
low because it was rapidly metabolized in intestines and liver into conjugated forms:glucuronate
and sulfonate.The most abundant resveratrol metabolites observed in humans, rats, and mice are
trans-resveratrol-3-O-glucuronide and trans-resveratrol-3-sulfate [61]. Walle suggested sulfate
conjugates are the primary source of activity [62]. Wang et al. (2008) also suggested the
glucuronides, and Boocock et al. (2007) also emphasized the need for further study of the effects
of the metabolites.
Mechanism of Action
The ability of resveratrol to enhance life extension are not fully understood, but scientists
believed that the compound appear to mimic several of the biochemical effects of calorie
restriction. Some studies indicate that resveratrol activates Sirtuin 1(SIRT1) and PGC-1α and
improve functioning of the mitochondria [62]. The mechanism may include direct quenching of
reactive oxygen species, inhibition of enzymes, formation of chelates, activation of anti-oxidant
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enzymes, etc. Scientists in the field of computational chemistry have proposed two main
mechanisms responsible for free radical scavenging processes of chain-breaking anti-oxidant
ArOH:
a)

H-atom transfer (1) , (b) One electron transfer (2)

Scheme 1. Free radical scavenging mechanism
Both mechanisms are important for the scavenging activity of reactive species by an
ArOH in a certain chemical or biological systems and may occur at the same time [63]. It is
important to note that, in the second mechanism (one electron transfer) the Hydrogen bonding is
normally retained as in the parent molecule contributing to a further stabilization. Resveratrol
also acts as an anti-inflammatory agent by inhibiting cyclooxygenase (COX) activity [64] and by
releasing cytokines from macrophages in chronic obstructive pulmonary disease (COPD). Other
data from cell culture and animal experiments suggest that it plays a role in cancer
chemoprevention during initiation, promotion, and progression of carcinogenesis. Resveratrol
also inhibited the enzymes CYP1A1, CYP1A2, and CYP1B1 in tumor cells [65].
Derivatives of Resveratrol
Since the discovery of resveratrol in 1939, there has been intense research about this
stilbenoid that has revealed some setbacks about the potency of this compound as chemo
preventative agent. Studies have revealed that because of the many targets known to interact with
Res, it is very difficult to pinpoint which targets is most important for a given disease state [66].
For this reason scientists are developing resveratrol derivatives that could exhibit selectivity for
only one target. Another documented setback of resveratrol is its lack of potency and the need
for high dosage administration; hence, there is the need to modify this compound to increase its
potency. The problem of resveratrol having limited bioavailability has also been documented. It
is believed that circulating resveratrol has a serum half-life of 8-14 min because it is rapidly
metabolized by sulfation and glucuronation [67]. Res 3-sulfate and res 3-glucuronide, the two
primary metabolites of resveratrol, have both been shown to exhibit far lower affinity for COX-1
and COX-2 [68].
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It is been suggested that for resveratrol to be effectively used as a chemotherapeutic
agent, modified analogues with comparable activity that lack the hydroxyl groups and hence
could not be sulfated or glucuronated must be synthesized [69].
Aliphatic acids and their ester or ether derivatives of resveratrol have been found to
possess good water solubility and increased bioavailability as shown in Figure 5. Jiang reported
that compounds 1a and 1b did not show any improved solubility when measured in either water
or phosphate buffer compared to their aliphatic acids 2a and 2b which showed improved water
solubility (PH 7). Jiang also reported that the binding affinity of compound 2a and 2b for Human
serum albumin (HSA) was higher than that of Res and as the number of chain of the aliphatic
acid group increases so as the binding affinity [70].

Figure 5. Derivatives of resveratrol by Jiang [70]

In 2007 Huang et al. reported that methylation of three hydroxyl groups of trans-Res
could improve the anti-tumor activity .They suggested the increased cytotoxic activities of the
modified Res could be attributed to the increased lipophilic activity of these compounds, which
might increase the permeability of the cell membranes, Figure 6 .They also concluded that
compound with alkyl ring amino side chains 3a and 3b showed better cytotoxic activities than
those containing aromatic ring, 3c. Compound 3d was found to show the highest anti-tumor
activity but they could not explain this observation [71].
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Figure 6. Derivatives of resveratrol by Huang et al. [71]
Chemical Synthesis of Resveratrol
Most medicinally important polyphenols occurs naturally in plants and effort to isolate
them in their natural form is a problem due to insufficient and complex technological procedures.
In view of this, there is the need to encourage synthetic analogues of these compounds. There
have been several synthetic pathways to produce resveratrol and two of them have been outlined
in Schemes 2 and 3. Scheme 2 was developed by Polunin et al. [72]. Scheme 3 was developed by
Mingfu Wang et al. [73].
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Scheme 2. Chemical synthesis of resveratrol by Polunin et al.
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Scheme 3. Chemical synthesis of resveratrol by Mingfu Wang et al.

Purpose of this Research
The fundamental objective of this research is to synthesize a water soluble anti-cancer
compound. Low water solubility and low bioavailability of chemotherapeutic agents are some of
the big challenges facing synthetic organic chemists and most pharmaceutical industries.
Derivatives and analogues of potential chemo preventative compounds are being synthesized and
evaluated to ascertain their bioavailability and water solubility. In this research, attempt was
made to modify Juglone into water soluble derivative, but we could not reproduce the result and
therefore there was the need to change the direction of the research to include modification of
resveratrol.
Proposed Synthetic Pathway for Synthesis of Juglone
The synthesis of Juglone 2 was a cupper catalyzed oxidation of dihydroxynaphthalene 1
as outlined in Scheme 4 [74].

Scheme 4. Synthesis of Juglone
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Scheme 5. Mechanism for oxidation of 1, 5-dihydroxynaphthalene

Proposed Synthetic Pathway for Modification of Juglone
Two synthetic schemes were employed as part of the efforts to modify Juglone: Scheme
6 and Scheme 8. Scheme 6 involved room temperature esterification of juglone using Bocprotected amino acids in the presence of DicyclohexylCarbodiimide (DCC) and
Dimethylaminopyridine (DMAP). The purpose of using DCC and DMAP is to activate the Boc
protected amino acid which will ensure SN2 attack by the alcohol group (Scheme 7). This
pathway was not successful and it was therefore abandoned. Scheme 8 is based on Williamson‟s
ether synthesis using bromoester as the alkylating agent. Weak base K2CO3 was used to
deprotonate the hydroxyl group of the Juglone to form phenoxide which was then alkylated with
the bromo ester via SN2 mechanism (Scheme 9).
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Scheme 6. Room temperature esterification of Juglone

Scheme 7. Mechanism for Room Temperature Esterification of Juglone
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Scheme 8. Modification of Juglone by Williamson Etherification

Scheme 9. Mechanism for Williamson Ether Synthesis

Proposed Synthetic Pathway for Modification of Resveratrol
Modification of the trans-Res was performed by selective alkylation of para-OH group
using Williamson‟s ether synthesis approach to obtain the mono alkylated product. (Mechanism
is similar to Scheme 9). The phenoxide form from deprotonation of para hydroxyl-group is more
stable compared to that of meta-proton abstraction as indicated by resonance structures in
Scheme 11 and 12 respectively.

32

33

34

Proposed Synthetic Pathway for Synthesis of Methyl 4-Bromobutyrate

Compound 6 was synthesized by employing Fisher esterification reaction between 4bromobutyric acid and methanol as shown in Scheme 13.

Scheme 13. Synthetic Pathway for 4-Bromomethylbutyrate by Fischer esterification
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Scheme 14. Mechanism for Fischer esterification
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CHAPTER 2
RESULTS AND DISCUSSION

Synthesis of 5-hydroxy-1, 4 -naphthoquinone (Juglone) 2

Compound 2 was obtained as orange crystals after purification of the crude product
using soxhlet extraction method based on the previous reported method [74]. A moderate yield
of 30% was obtained that is relatively lower than the reported yield of 33% [74]. The oxidation
reaction occurs by free radical mechanism as shown in Scheme 5.

Synthesis of Methyl 5-[(1, 4-naphthenedionyl) oxy]-acetate 4

The synthesis of this compound was based on the theory of Williamson‟s ether synthesis
where the base reacts to form the phenoxide. The phenoxide reacted with the bromoester to yield
30% product (Scheme 8). Unfortunately this procedure could not be reproduced. For this reason
there was the need to change the direction of our research to include resveratrol.

Synthesis of Methyl 4-Bromobutyrate 6

In order to synthesize our novel Res derivative, there was the need to synthesize the
alkylating agent 6. A white-yellow liquid was obtained by reaction of the bromobutyric acid with
methanol catalyzed by sulfuric acid. The reaction mechanism followed the Fisher esterification
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reaction as shown in Scheme 13.
Synthesis of Methyl 4-{-[(1E)-2-(3, 5,-dihydroxyphenyl)-ethenyl] - phenoxy} butyrate 7

Compound 7 was obtained as white solid crystals with low yield of 10%. The low yield
could be attributed to highly competitive side products such as di and tri alkylated products. The
regiochemistry of the alkylating step is very crucial for selective product formation. Effort was
made to control selectivity of alkylation by varying reaction conditions, and the summary of
results is shown in Table1.
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Table 1. Summary of Reaction Results

RES
(mol

K2CO3

Br(CH2)3COOMe

Temperature

Mono

Di

Tri

Recovered Reaction Time

(mol ratio)

(mol ratio)

(oC)

(%)

(%)

(%)

(RES) (%)

(Hrs)

ratio)

1

2

1

≥70

None

None

80

20

12

1

2

1

25

None

None

None

100

12

1

1.5

0.7

60

3

25

30

42

12

1

50

10

35

20

35

12

2
1

2

39

10

Millimole amount of the alkylating agent and reaction temperature were the two main
factors controlling selectivity. At high temperatures the selectivity was low and tri alkylated
product was mainly the product. It was observed that at room temperature there would be no
reaction. The best temperature for the reaction was found to be 50oC. It was also found that the
molar equivalent ratio of 1:2:1 with respect to resveratrol, potassium carbonate, and the bromo
ester was suitable for the reaction. It was observed that addition of the bromoester in dropwise
was very important for controlled selectivity. It must be noted that in all the cases tri and di
alkylated products were separated. Another interesting observation was the fact that the mono
alkylated product is present in two forms: mono alkylation occurring at the meta position
together with the expected mono alkylated product at para position. This was revealed by
H

NMR (Appendix E) after column purification and hence recrystalization method was used to

purify the product.
Conclusion
The objective of the research was partly fulfilled due to time constrain by synthesizing a
novel intermediate (compound 7) that could be subjected to further chemical transformation to
obtain the amino acid derivatives. The low yield (10%) was attributed to the competitive side
reactions and also the need to recrystallize the product to remove the isomer that was present
even after column purification. We also made an effort to determine the best condition to reduce
side reactions in other to improve the yield. The result obtained could be useful for future
experimentation to obtain a better yield.
It must be noted that Juglone was also synthesized based on the initial objective in
relatively good yield 30% (reported yield of 33%). It should be noted that one of the factors that
was affecting the reaction to obtained compound 4 was hydrogen bonding between the H of
hydroxyl group and the carbonyl oxygen group on the Juglone structure 2. Reaction temperature
must be carefully studied to overcome the hydrogen bonding in other to obtain good results.
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CHAPTER 3
EXPERIMENTAL
General Methods
Resveratrol and other commercial reagents were used without further purification and
1

13

were purchased from sigma (St.Louis, MO, USA). All proton ( H) and carbon ( C) NMR
spectra were recorded on JEOL‐NMR Eclipse spectrometer operating at 400 MHz and 100 MHz
for proton and carbon nuclei respectively. Spectra were obtained using CDCl3 unless otherwise
stated. Chemical shifts were recorded as delta values in parts per million (ppm) relative to TMS.
The multiplicity of signals is reported as follows: s, singlet; d, doublet; m, multiplet. Thin layer
chromatography (TLC) was performed with silica gel plate using appropriate solvent mixture
and visualized under UV Fluorescent indicator. Column chromatography was performed using
silica gel and appropriate solvent. Melting points were recorded on Cambridge MEL-TEMP
instruments and were not corrected. All weighing were done using Mettler PJ360 Delta Range
scale unless otherwise stated.
Experimental Procedures
Synthesis of 5-hydroxy-1, 4-naphthoquinone (Juglone) 2

A suspension of 1.2 g (0.012 mol) CuCl in acetonitrile (150 mL) was placed in three-necked
flask. A strong current of air was bubbled through it. A suspension of 1, 5-dihydroxynaphthalene
(3.0 g, 0.019 mol) in acetonitrile (150 mL) was added with vigorous stirring at room temperature
in a dark over 30 min, and the resultant mixture stirred for 7 h. The mixture was filtered and
washed with acetonitrile and the solvent removed under reduced pressure. Soxhlet extractor was
used to purify the crude using n-heptane as solvent to give 2 (0.36 g, 30%) as an orange solid
[74]. The reported yield was 33%, M.p 155-159oC; Lit M.p 154-161 oC. 1HNMR (400 MHz,
CDCl3): δ 6.94 (s, Ar-H) 7.29 (dd, J=6.3, 2.9Hz); 7.64 (m, Ar-H); 11.9 (s, OH); 13CNMR (100
MHZ, CDCl3) δ 115.05, 119.27, 124.64, 131.83, 136.68, 138.76, 139.69, 161.53, 184.37, 190.40
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Synthesis of Methyl 4-Bromobutyrate 6

To a one-neck round-bottomed flask were added 5 g (0.03 mol) 4-bromobutyric acid,
twenty-five milliliters of methanol was added followed by 2 drops of sulfuric acid and the
mixture was reflux for 16 hrs (60oC). The mixture was concentrated, washed with 5% NaHCO3,
and extracted with diethyl ether. The extract was dried with MgSO4 (anhydrous) and the ether
was evaporated to afford 4.7 g (94%) 6. 1H NMR (400 MHz, CDCl3) δ 3.65 (s, 3H, OCH3); 3.45
(t, 2H, CH2); 2.49 (t, 2H, CH2); 2.17 (m, 2H, CH2).
Synthesis of Methyl 4-{-[(1E)-2-(3, 5,-dihydroxyphenyl)-ethenyl]-phenoxy} butyrate 7

To a one-neck round bottomed flask were added 0.3 g (1.3 mmol) resveratrol, 15 mL
acetone, and 0.36 g K2CO3 (2.8 mmol). 0.235 g (1.3 mmol) of compound 6 was added in
dropwise( 50% added initially and stirred for 6 hrs and the remaining half added and stirred for
the next 10 hrs) at the temperature of 50oC. The mixture was decomposed with concentrated
ammonium chloride, extracted with ethyl acetate, and dried with anhydrous MgSO4. The solvent
was evaporated and the resulting mixture was purified using column chromatography (25-40% of
acetone in hexane volume) to give compound 7 (0.03 g, 10%). The compound was recrystallized
from ethyl acetate hexane (1:10 volume) to obtain 0.02 g, (6.7%), RF value 0.65 (Acetone
/hexane 40:60 v/v). Mp.148-150oC. 1HNMR (CD3COCD3, 400 MHz, ppm) δ 2.038 (t, 2H,
CH2); δ 2.5 (m, 2H, CH2); δ 3.6 (s, 3H,CH3); δ 4.03 (t, 2H, OCH2); 8.2 ( s, 2H, OH); 7.5 ( d, 2H,
Ar-H), 6.94 (m, 4H, Ar-H ); 6.5 (s, 2H, Ar-H); 6.29 (s, 1H, Ar-H);
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C NMR (CD3COCD3

,100 MHz ,ppm) δ 28.6, 50.8, 66.7, 101.95, 104.91, 114.68, 126.7, 127.8, 127.9, 130.23,
139.9, 158.78, 173.00.
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APPENDICES
APPENDIX A: 1HNMR Spectrum of Compound 2 in CDCl3
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APPENDIX B: 1HNMR of Compound 5 in CDCl3

48

APPENDIX C: 1HNMR Spectrum of Compound 7 in CD3COCD3
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APPENDIX D: 13C NMR of Compound 7 inCD3COCD3
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APPENDIX E: 1HNMR of Mixture of Compound 7 and its Isomer Compound (Before
Recrystalization)
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APPENDIX F: 1HNMR of Compound 4 in CDCl3
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